🇺🇸 FDA
Pipeline program

Atorvastatin Oral Tablet

IRB00256402

Phase 2 small_molecule active

Quick answer

Atorvastatin Oral Tablet for Mild Cognitive Impairment is a Phase 2 program (small_molecule) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Mild Cognitive Impairment
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials